Sydney, Australia

Vaxxas Pty Limited

Calculating rank
USPTO Granted Patents = 16


Trademarks = 1

Forward Citations = 84

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Mark Anthony Fernance Kendall (10 out of 17 patents)

silverMedal Christopher Flaim (6 out of 6 patents)

bronzeMedal Michael Carl Junger (5 out of 10 patents)

4.  Michael Lawrence Crichton (5 out of 5 patents)

5.  Stefano Meliga (3 out of 3 patents)

6.  Xi Wang (2 out of 2 patents)

7.  Neil Harris (2 out of 2 patents)

8.  Sasikaran Kandasamy (2 out of 2 patents)

9.  Alexandra Christina Isabelle Depelsenaire (2 out of 2 patents)

10.  Pierre Armand Vincent Lemaire (2 out of 2 patents)

11.  Germain Fernando (1 out of 2 patents)

12.  Xianfeng Chen (1 out of 7 patents)

13.  Alexander Bernard Ansaldo (1 out of 1 patent)

14.  Robert John Falconer (1 out of 1 patent)

15.  Tarl W Prow (1 out of 4 patents)


16 patents:

Company Overview
Vaxxas Pty Limited is an innovative biotechnology company based in Sydney, Australia, specializing in the development of advanced vaccine delivery technologies. The company focuses on its proprietary nanopatch platform, which aims to enhance the efficacy and accessibility of vaccines through a needle-free delivery method. By leveraging micro-needle technology, Vaxxas seeks to improve immunization rates and patient experiences, contributing to global health initiatives and addressing unmet medical needs in vaccine distribution.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 17 2026

16 Patents

#12 in Sydney

#230 in Australia

#37,986 in the World

Sydney, AU
Sydney, Australia
Forward Citations = 84

16 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vaxxas Pty Limited. Retrieved from https://idiyas.com/company/vaxxas-pty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…